Abstract:The design and development of contrast agents for magnetic resonance imaging (MRI) with improved chemical stability and higher contrasting capability for clinical translation compared to conventional contrast agents are still of great interest. In this study, a facile and universal approach was explored for controllable functionalization of red-emissive carbon nanodots (RCNDs) with diethylenetriaminepentaacetic anhydride (DTPA) for chelation of gadolinium. A series of accurate characterizations were used to control each step of the synthesis. The functionalization did not alter the band gap of the carbon nanodots, preserving their inherent far-red fluorescence. The as-prepared RCND-DTPA-Gd displayed a high colloidal stability with negligible Gd leakage. The nanodots also showed a better magnetic resonance relaxivity than commercial MRI agents. RCND-DTPA-Gd had good biocompatibility <i>in vivo</i> even at high doses. The systemically injected RCND-DTPA-Gd were found to be efficiently excreted through the renal route, a feature that further minimizes the potential toxicity risks. All these properties suggest that carbon nanodots can be well designed as efficient carriers of Gd, resulting in potential clinical tools as dual MRI/fluorescence functional probes for imaging applications. The approach described here could pave the pathway to a flexible strategy for the controllable functionalization of small-sized nanoparticles including carbon dots, rendering them more versatile. This work is expected to promote the future translation of carbon nanodots into clinical trials.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsanm.0c02993?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsanm.0c02993</a>.Organ distribution of RCND-DTPA-Gd in vivo (Videos S1 and S2) (<a class="ext-link" href="/doi/suppl/10.1021/acsanm.0c02993/suppl_file/an0c02993_si_001.zip">ZIP</a>)Synthesis of DTPA ligand (Scheme S1), additional HAADF-STEM images of the RCND-DTPA-Gd sample (Figure S1), DLS of RCND-DTPA-Gd (Figure S2), FL spectra of CND-DTPA-Gd (Figure S3), cell viability of RCND-DTPA-Gd (Figure S4), and the hematological and biochemical parameters of RCND-DTPA (Tables S1 and S2) (<a class="ext-link" href="/doi/suppl/10.1021/acsanm.0c02993/suppl_file/an0c02993_si_002.pdf">PDF</a>)This article has not yet been cited by other publications.

Gd-Dots with Strong Ligand-Water Interaction for Ultrasensitive Magnetic Resonance Renography

Exceedingly Small Gadolinium Oxide Nanoparticles with Remarkable Relaxivities for Magnetic Resonance Imaging of Tumors

Gadolinium-Incorporated Carbon Nanodots for T 1 -Weighted Magnetic Resonance Imaging

High relaxivity Gd3+-based organic nanoparticles for efficient magnetic resonance angiography

Gd-encapsulated Carbonaceous Dots with Efficient Renal Clearance for Magnetic Resonance Imaging.

Synthesis of a Highly Stable Gadolinium Based MRI Contrast Agent

Formation of Nanosized Gd(III) Coordination Networks with Tripodal Amine-N-oxide Type Ligand Through Microemulsions to Achieve High Relaxivity and Exceptional Stability for MRI Applications

Preparation of Mn2+@PolyDOPA-b-polysarcosine Micelle As MRI Contrast Agent with High Longitudinal Relaxivity

Facile Preparation of a New Gadofullerene-Based Magnetic Resonance Imaging Contrast Agent with High 1H Relaxivity

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Stable Gadolinium Based Nanoscale Lyophilized Injection for Enhanced MR Angiography with Efficient Renal Clearance

Enhancing the magnetic relaxivity of MRI contrast agents via the localized superacid microenvironment of graphene quantum dots

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

α-Aryl Substituted GdDOTA Derivatives, the Perfect Contrast Agents for MRI?

Design and synthesis of chiral DOTA-based MRI contrast agents with remarkable relaxivities

Ultrasmall gadolinium hydrated carbonate nanoparticle: An advanced T 1 MRI contrast agent with large longitudinal relaxivity

Enhancement of Relaxivity Rates of Gd-Dtpa Complexes by Intercalation into Layered Double Hydroxide Nanoparticles

Preparation of MRI-visible Gadolinium Methacrylate Nanoparticles with Low Cytotoxicity and High Magnetic Relaxivity

Improving Longitudinal Transversal Relaxation of Gadolinium Chelate Using Silica Coating Magnetite Nanoparticles

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

Boosting Vascular Imaging‐Performance and Systemic Biosafety of Ultra‐Small NaGdF 4 Nanoparticles via Surface Engineering with Rationally Designed Novel Hydrophilic Block Co‐Polymer